Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K K Manghani

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|November 15, 1975
Urinary and serum octopamine in patients with portal-systemic encephalopathyK K Manghani, M R Lunzer, B H Billing, et al.
British Journal of Clinical Pharmacology|October 1, 1981
Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteersJ A Steiner, A Clancy, K K Manghani, et al.
Lancet (London, England)|August 30, 1975
Impaired cardiovascular responsiveness in liver diseaseM R Lunzer, S P Newman, A G Bernard, et al.
British Journal of Clinical Pharmacology|December 1, 1983
Pulmonary effects in man of oral prizidilol hydrochloride (SK&F 92657), a new antihypertensive agentW M Edmondstone, J F Waller, K K Manghani, et al.
British Journal of Clinical Pharmacology|October 1, 1981
Cardiovascular effects in man of intravenous prizidilol hydrochloride (SK&F 92657); a new antihypertensive agentW M Edmonstone, K K Manghani, A J Bell, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|November 15, 1975
Urinary and serum octopamine in patients with portal-systemic encephalopathyK K Manghani, M R Lunzer, B H Billing, et al.
British Journal of Clinical Pharmacology|October 1, 1981
Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteersJ A Steiner, A Clancy, K K Manghani, et al.
Lancet (London, England)|August 30, 1975
Impaired cardiovascular responsiveness in liver diseaseM R Lunzer, S P Newman, A G Bernard, et al.
British Journal of Clinical Pharmacology|December 1, 1983
Pulmonary effects in man of oral prizidilol hydrochloride (SK&F 92657), a new antihypertensive agentW M Edmondstone, J F Waller, K K Manghani, et al.
British Journal of Clinical Pharmacology|October 1, 1981
Cardiovascular effects in man of intravenous prizidilol hydrochloride (SK&F 92657); a new antihypertensive agentW M Edmonstone, K K Manghani, A J Bell, et al.
Pageof 1